Challenges in pharmacogenetics

被引:8
作者
Cascorbi, Ingolf [1 ]
Bruhn, Oliver [1 ]
Werk, Anneke N. [1 ]
机构
[1] Univ Hosp Schleswig Holstein, Inst Expt & Clin Pharmacol, D-24105 Kiel, Germany
关键词
CYP2C19; GENOTYPE; CYP2D6; POLYMORPHISM; ASSOCIATION; CLOPIDOGREL; METABOLISM; IMPACT; RISK; PHARMACOKINETICS; HYDROXYLATION;
D O I
10.1007/s00228-013-1492-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The attempt to optimize drug treatment of patients by using evidenced-based medicine considering individual physiological and disease-related conditions is standard of modern medicine. Pharmacogenetics (PGx) has contributed to individualization considering hereditary genetic information; however, increasingly, pharmacogenomics is becoming essential, particularly in relation to modern oncology. New technologies such as next-generation sequencing and rapid development of computational and information sciences will help to better elucidate the consequences of genetic variation, considering also epigenetics and gene-environmental interactions and their translation into clinically relevant individual phenotypes. This review highlights the current challenging and most promising examples of PGx.
引用
收藏
页码:S17 / S23
页数:7
相关论文
共 49 条
[41]   Pharmacogenetics of opioids [J].
Somogyi, Andrew A. ;
Barratt, Daniel T. ;
Coller, Janet K. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (03) :429-444
[42]   Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function [J].
Stingl, J. C. ;
Brockmoeller, J. ;
Viviani, R. .
MOLECULAR PSYCHIATRY, 2013, 18 (03) :273-287
[43]   The cancer genome [J].
Stratton, Michael R. ;
Campbell, Peter J. ;
Futreal, P. Andrew .
NATURE, 2009, 458 (7239) :719-724
[44]   Thiopurine treatment in inflammatory bowel disease - Clinical pharmacology and implication of pharmacogenetically guided dosing [J].
Teml, Alexander ;
Schaeffeler, Elke ;
Herrlinger, Klaus R. ;
Klotz, Ulrich ;
Schwab, Matthias .
CLINICAL PHARMACOKINETICS, 2007, 46 (03) :187-208
[45]   Paraoxonase-1 Q192R Polymorphism and Antiplatelet Effects of Clopidogrel in Patients Undergoing Elective Coronary Stent Placement [J].
Trenk, Dietmar ;
Hochholzer, Willibald ;
Fromm, Martin F. ;
Zolk, Oliver ;
Valina, Christian M. ;
Stratz, Christian ;
Neumann, Franz-Josef .
CIRCULATION-CARDIOVASCULAR GENETICS, 2011, 4 (04) :429-436
[46]   Multiple personal genomes await [J].
Venter, J. Craig .
NATURE, 2010, 464 (7289) :676-677
[47]   Association of sirolimus adverse effects with m-TOR, p70S6K or Raptor polymorphisms in kidney transplant recipients [J].
Woillard, Jean-Baptiste ;
Kamar, Nassim ;
Rousseau, Annick ;
Rostaing, Lionel ;
Marquet, Pierre ;
Picard, Nicolas .
PHARMACOGENETICS AND GENOMICS, 2012, 22 (10) :725-732
[48]   High Frequency of Occurrence of CYP2D6 Gene Duplication/Multiduplication Indicating Ultrarapid Metabolism Among Suicide Cases [J].
Zackrisson, A. L. ;
Lindblom, B. ;
Ahlner, J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (03) :354-359
[49]   Effect of the P450 oxidoreductase *28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers [J].
Zhang, Jing-Jing ;
Zhang, Hua ;
Ding, Xiao-Liang ;
Ma, Sheng ;
Miao, Li-Yan .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) :807-812